Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury

NCT07197957 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-30

No results posted yet for this study

Summary

To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).

Conditions

Sponsors & Collaborators

  • BayCare Health System

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-11
Primary Completion
2026-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07197957 on ClinicalTrials.gov